Soleno Therapeutics Inc banner

Soleno Therapeutics Inc
NASDAQ:SLNO

Watchlist Manager
Soleno Therapeutics Inc Logo
Soleno Therapeutics Inc
NASDAQ:SLNO
Watchlist
Price: 38.3 USD -1.95% Market Closed
Market Cap: $2.1B

Wall Street
Price Targets

SLNO Price Targets Summary
Soleno Therapeutics Inc

Wall Street analysts forecast SLNO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SLNO is 114.16 USD with a low forecast of 60.6 USD and a high forecast of 152.25 USD.

Lowest
Price Target
60.6 USD
58% Upside
Average
Price Target
114.16 USD
198% Upside
Highest
Price Target
152.25 USD
298% Upside
Soleno Therapeutics Inc Competitors:
Price Targets
CDNA
CareDx Inc
34% Upside
SUPN
Supernus Pharmaceuticals Inc
17% Upside
CSGP
CoStar Group Inc
68% Upside
VRNS
Varonis Systems Inc
50% Upside
INO
Inovio Pharmaceuticals Inc
381% Upside

Revenue
Forecast

41% / Year
Past Growth
100% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
41% / Year
Past Growth
100% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 12 years the compound annual growth rate for Soleno Therapeutics Inc's revenue is 41%. The projected CAGR for the next 2 years is 100%.

Operating Income
Forecast

N/A
Past Growth
622% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
622% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

The compound annual growth rate of Soleno Therapeutics Inc's operating income for the next 2 years is 622%.

Net Income
Forecast

N/A
Past Growth
330% / Year
Estimated Growth
Estimates Accuracy
-93%
Average Miss
N/A
Past Growth
330% / Year
Estimated Growth
Estimates Accuracy
-93%
Average Miss

The compound annual growth rate of Soleno Therapeutics Inc's net income for the next 2 years is 330%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SLNO's stock price target?
Price Target
114.16 USD

According to Wall Street analysts, the average 1-year price target for SLNO is 114.16 USD with a low forecast of 60.6 USD and a high forecast of 152.25 USD.

What is Soleno Therapeutics Inc's Revenue forecast?
Projected CAGR
100%

For the last 12 years the compound annual growth rate for Soleno Therapeutics Inc's revenue is 41%. The projected CAGR for the next 2 years is 100%.

What is Soleno Therapeutics Inc's Operating Income forecast?
Projected CAGR
622%

The compound annual growth rate of Soleno Therapeutics Inc's operating income for the next 2 years is 622%.

What is Soleno Therapeutics Inc's Net Income forecast?
Projected CAGR
330%

The compound annual growth rate of Soleno Therapeutics Inc's net income for the next 2 years is 330%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett